BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24597959)

  • 21. Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib.
    Chang SC; Liao CH; Wang SY; Tsai CY; Chiang KC; Cheng CT; Yeh TS; Chen YY; Ma MC; Liu CT; Yeh CN
    Medicine (Baltimore); 2015 Jun; 94(24):e1014. PubMed ID: 26091448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis.
    Wang J; Yin Y; Shen C; Yin X; Cai Z; Pu L; Fu W; Wang Y; Zhang B
    Medicine (Baltimore); 2020 Feb; 99(9):e19275. PubMed ID: 32118738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG).
    Duffaud F; Meeus P; Bertucci F; Delhorme JB; Stoeckle E; Isambert N; Bompas E; Gagniere J; Bouché O; Toulmonde M; Salas S; Blay JY; Bonvalot S;
    Eur J Surg Oncol; 2017 Jun; 43(6):1110-1116. PubMed ID: 28433494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rectal gastrointestinal stromal tumor: a clinical and pathologic analysis].
    Chang XY; Ma ZQ; Li Y; Zhou WX
    Zhonghua Bing Li Xue Za Zhi; 2016 Jul; 45(7):462-6. PubMed ID: 27430691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.
    Wilkinson MJ; Fitzgerald JE; Strauss DC; Hayes AJ; Thomas JM; Messiou C; Fisher C; Benson C; Tekkis PP; Judson I
    Br J Surg; 2015 Jul; 102(8):965-71. PubMed ID: 25970743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal gastrointestinal stromal tumor: clinical features, endoscopic findings and prognosis.
    Kim JB; Ye BD; Lee JL; Lim SB; Yu CS; Kim JC; Kang YK; Byeon JS; Myung SJ; Yang SK; Kim JH
    Hepatogastroenterology; 2014; 61(129):70-5. PubMed ID: 24895796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant Imatinib Therapy Followed by Intersphincteric Resection for Low Rectal Gastrointestinal Stromal Tumors.
    Kaneko M; Nozawa H; Emoto S; Murono K; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Watanabe T
    Anticancer Res; 2017 Sep; 37(9):5155-5160. PubMed ID: 28870948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study.
    Qi J; Liu HL; Ren F; Liu S; Shi W; Liu WH; Cai GQ; Liao GQ
    World J Surg Oncol; 2020 Apr; 18(1):70. PubMed ID: 32264886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing prognostic factors of long-term survival after surgery for colorectal gastrointestinal stromal tumours.
    Yang S; Maspero M; Holubar SD; Hull TL; Lightner AL; Valente MA; Gorgun E; Kalady MF; Steele SR; Liska D
    Colorectal Dis; 2023 Dec; 25(12):2325-2334. PubMed ID: 37876119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal Stromal Tumours of the Rectum - Evaluating the National Registry Data with Respect to its Use in Clinical Practice.
    Svatoň R; Kala Z; Kysela P; Procházka V; Eid M; Andrašina T; Poredská K; Strenková J; Chloupková R; Kunovsky L
    Klin Onkol; 2019; 32(2):117-123. PubMed ID: 30995851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG).
    Duffaud F; Meeus P; Bachet JB; Cassier P; Huynh TK; Boucher E; Bouché O; Moutardier V; le Cesne A; Landi B; Marchal F; Bay JO; Bertucci F; Spano JP; Stoeckle E; Collard O; Chaigneau L; Isambert N; Lebrun-Ly V; Mancini J; Blay JY; Bonvalot S
    Eur J Surg Oncol; 2014 Oct; 40(10):1369-75. PubMed ID: 24994075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Curative resection for bulky rectal gastrointestinal stromal tumor after neoadjuvant imatinib mesylate].
    Kobayashi H; Uetake H; Higuchi T; Enomoto M; Yasuno M; Iida S; Yoshimura T; Ishikawa T; Ishiguro M; Kato S; Ono H; Kikuchi A; Yamauchi S; Sugihara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2620-2. PubMed ID: 21224658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World.
    Nishida T; Cho H; Hirota S; Masuzawa T; Chiguchi G; Tsujinaka T;
    Ann Surg Oncol; 2018 Jul; 25(7):1961-1969. PubMed ID: 29752602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort.
    IJzerman NS; Mohammadi M; Tzanis D; Gelderblom H; Fiore M; Fumagalli E; Rutkowski P; Bylina E; Zavrakidis I; Steeghs N; Bonenkamp HJ; van Etten B; Grünhagen DJ; Rasheed S; Tekkis P; Honoré C; van Houdt W; van der Hage J; Bonvalot S; Schrage Y; Smith M
    Eur J Surg Oncol; 2020 Jun; 46(6):1124-1130. PubMed ID: 32224070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
    Hawkins AT; Wells KO; Krishnamurty DM; Hunt SR; Mutch MG; Glasgow SC; Wise PE; Silviera ML
    Ann Surg Oncol; 2017 May; 24(5):1195-1201. PubMed ID: 28050726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of prognostic prediction models for rectal gastrointestinal stromal tumor.
    Jiaxin L; Peiyun Z; Zheng T; Wei Y; Shanshan S; Lei R; Zhengwen X; Yong F; Xiaodong G; Anwei X; Kuntang S; Yingyong H
    Aging (Albany NY); 2020 Jun; 12(12):11416-11430. PubMed ID: 32561689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.